33 related articles for article (PubMed ID: 1583828)
1. Improved biocompatibility of extracorporeal circulation by the use of auto-oxygenation instead of artificial oxygenator in perfusion circuit.
Bochenek A; Religa Z; Kustosz R; Wnuk-Wojnar AM; Wnuk R; Wojnar J; Woś S; Wites M; Zembala M; Spyt T
Nephrol Dial Transplant; 1991; 6 Suppl 3():75-80. PubMed ID: 1775272
[TBL] [Abstract][Full Text] [Related]
2. Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators.
Cavarocchi NC; Pluth JR; Schaff HV; Orszulak TA; Homburger HA; Solis E; Kaye MP; Clancy MS; Kolff J; Deeb GM
J Thorac Cardiovasc Surg; 1986 Feb; 91(2):252-8. PubMed ID: 3511328
[TBL] [Abstract][Full Text] [Related]
3. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.
Chenoweth DE; Cooper SW; Hugli TE; Stewart RW; Blackstone EH; Kirklin JW
N Engl J Med; 1981 Feb; 304(9):497-503. PubMed ID: 7453783
[TBL] [Abstract][Full Text] [Related]
4. Biocompatibility of extracorporeal circulation with autooxygenation.
Bochenek A; Religa Z; Kokot F; Wnuk-Wojnar AM; Wojnar J; Wnuk R; Gallert G; Skiba J
Eur J Cardiothorac Surg; 1992; 6(8):397-402. PubMed ID: 1389244
[TBL] [Abstract][Full Text] [Related]
5. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation.
van Oeveren W; Kazatchkine MD; Descamps-Latscha B; Maillet F; Fischer E; Carpentier A; Wildevuur CR
J Thorac Cardiovasc Surg; 1985 Jun; 89(6):888-99. PubMed ID: 3158783
[TBL] [Abstract][Full Text] [Related]
6. [Use of cardiopulmonary bypass decreases leukocyte count and activation of the complement system].
Bochenek A; Religa Z; Kokot F; Knapik P; Wnuk R; Komarski K; Wojnar J; Pietrzycki A; Skiba J
Kardiol Pol; 1992; 36(2):67-72. PubMed ID: 1583828
[TBL] [Abstract][Full Text] [Related]
7. Deleterious effects of complement activation on the lungs during extracorporeal circulation and its inhibition by FUT-175.
Miyamoto Y; Matsuda H; Kawashima Y
J Biomater Appl; 1989 Jul; 4(1):56-68. PubMed ID: 2664117
[TBL] [Abstract][Full Text] [Related]
8. Initiation of white cell activation during cardiopulmonary bypass: cytokines and receptors.
Cameron D
J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S1-5. PubMed ID: 8938277
[TBL] [Abstract][Full Text] [Related]
9. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins.
Moat NE; Shore DF; Evans TW
Eur J Cardiothorac Surg; 1993; 7(11):563-73. PubMed ID: 8297608
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer.
Kleczko EK; Kwak JW; Schenk EL; Nemenoff RA
Front Immunol; 2019; 10():954. PubMed ID: 31134065
[TBL] [Abstract][Full Text] [Related]
11. The inflammatory response to CPB: the role of leukocyte filtration.
Asimakopoulos G
Perfusion; 2002 May; 17 Suppl():7-10. PubMed ID: 12009089
[TBL] [Abstract][Full Text] [Related]
12. [Induction of interleukin-1 synthesis. A new criterion of biocompatibility of extracorporeal circuits].
Haeffner-Cavaillon N; Kazatchkine MD
Presse Med; 1991 May; 20(17):797-801. PubMed ID: 1829166
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
